COLOSSUS: Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions.
Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.
For more details about this innovative project and our aims see here.
The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.
ROYAL COLLEGE OF SURGEONS IN IRELAND (RCSI)
FUNDACIO PRIVADA INSTITUT D’INVESTIGACIO ONCOLOGIA DE VALL-HEBRON (VHIO)
UNIVERSITY COLLEGE DUBLIN (UCD)
INSTITUTE OF CANCER RESEARCH – ROYAL CANCER HOSPITAL, (ICR)
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG, (UHEI)
UNIVERSITA DEGLI STUDI DI TORINO, (UNITO),
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, (INSERM)
IRISH CLINICAL ONCOLOGY RESEARCH GROUP LIMITED LBG, (CTI)
OPTIMATA LTD, (OPTI)
GENEXPLAIN GMBH, (GEX)
EPIGENOMICS AG, (EPI)
PINTAIL LTD, (PT)